Company profile: CH Biomedical
1.1 - Company Overview
Company description
- Provider of ventricular assist device (VAD) technology utilizing an innovative magnetic levitation pump design, including the CH-VAD®, an implantable left ventricular assist system using full magnetic levitation to support heart function in patients with end-stage heart failure.
Products and services
- VAD Technology Development: Develops ventricular assist device technology utilizing an innovative MagLev-based pump design to improve implantable cardiac support for end-stage heart failure patients
- MagLev Pump Design: Architects innovative magnetic levitation pump design utilized in ventricular assist device technology to support heart function in end-stage heart failure applications, implantable
- CH-VAD®: An implantable left ventricular assist system using full magnetic levitation technology to support heart function in patients with end-stage heart failure
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CH Biomedical
Tissium
HQ: France
Website
- Description: Provider of synthetic, biodegradable, light-activated sealants, surgical adhesives, and biomaterial solutions for wound closure and tissue reconstruction, with a focus on minimally invasive surgery. Offerings include SETALIUM Vascular Sealant, ECLIPSIUM laparoscopic hernia repair system, biomorphic programmable polymers, IBD fistula-healing solutions, and COAPTIUM Connect for sutureless nerve repair.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tissium company profile →
Cardiva Medical
HQ: United States
Website
- Description: Provider of innovative vascular closure technology and devices to help the body heal after catheterization, including the VASCADE vascular closure system and Catalyst II and Catalyst III, which are designed to aid manual compression.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardiva Medical company profile →
AUM Cardiovascular
HQ: United States
Website
- Description: Provider of medical device manufacturing solutions specializing in the biotechnology, medical, and healthcare fields.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AUM Cardiovascular company profile →
Carmeda
HQ: Sweden
Website
- Description: Provider of hemocompatible surface coating for medical devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Carmeda company profile →
ivWatch
HQ: United States
Website
- Description: Provider of intravenous infiltration detection solutions, including the ivWatch Monitoring System that continuously monitors peripheral IVs to detect infiltrations and extravasations early with real-time notifications to clinicians; SmartTouch single-use sensor and reusable optical fiber sensor for flexible, comfortable, MRI-compatible IV site monitoring; and OEM solutions to embed the technology into patient monitors or infusion pumps.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ivWatch company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CH Biomedical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CH Biomedical
2.2 - Growth funds investing in similar companies to CH Biomedical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CH Biomedical
4.2 - Public trading comparable groups for CH Biomedical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →